论文部分内容阅读
美国FDA忠告:米托蒽醌(rnitoxantrone)为抗癌药,用该药治疗多发性硬化症在完成疗程后,所有患者均必须监察迟发性的心脏毒性,并于治疗前后监测病人的心室射血分数。此药上
US FDA Advises: ritonantrone is an anti-cancer drug used to treat multiple sclerosis. After completing the course of treatment, all patients must be monitored for delayed cardiotoxicity and monitor their ventricular ejection before and after treatment Blood score. This medicine